The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Abiraterone Aristo 250 mg tablets

Aristo Pharma GmbHPA1983/008/001

Main Information

Trade NameAbiraterone Aristo 250 mg tablets
Active SubstancesAbiraterone acetate
Dosage FormTablet
Licence HolderAristo Pharma GmbH
Licence NumberPA1983/008/001

Group Information

ATC CodeL02BX03 abiraterone


License statusAuthorised
Licence Issued07/05/2021
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable ListAbiraterone 250 mg Tablets
Interchangeable List CodeIC0123-130-002
Interchangeable List DocumentPDF of Interchangeable List
« Back